(22 March 2021) Last week EPSU and HOSPEEM (the representative social partners at the health and social services social dialogue) sent a letter to Commissioner Schmit about the European Commssion study on the protection of workers from exposure to hazardous medicinal products (HMP), including cytotoxic substances.
The study's content, which will assess four policy options concerning HMPs, is crucial for establishing safeguards for the 12 million healthcare workers currently exposed to HMPs.
The European Commission has announced its ‘coming’ publication since the end of 2020 and social partners and members of the European Parliament are eager to read the outcome of the report.
Given that this week European legislators will vote on the issue we are surprised that the European Commission has not come forward with the report that we believe has been finished for several months.
We hope Commissioner Schmit will respond to social partners before the trialogue starts on this issue so crucial for health workers.